Earnings Alerts

Kimberly Clark (KMB) Earnings: 1Q Ebitda Meets Estimates with Positive Surge in Net Income and Operating Profit

  • Kimberly-Clark Mexico reported a 1Q Ebitda of MXN3.89 billion, a 19% increase year over year, which met estimates.
  • The company’s net income was MXN2.08 billion, marking a 29% rise year over year. The estimated value was MXN2.05 billion.
  • Net sales amounted to MXN13.79 billion, a 1.8% increase from last year, slightly under the estimated MXN14.05 billion.
  • Gross profit stood at MXN5,829.00 quadrillion, compared to MXN4.92 billion the previous year. This surpassed the estimated MXN5.66 billion.
  • Operating profit was reported at MXN3.40 billion, a 22% increase from the previous year. This was above the anticipated MXN3.32 billion.
  • As of the latest update, Kimberly-Clark Mexico has received 11 buy recommendations, 3 hold recommendations, and 0 sell recommendations.

Kimberly Clark on Smartkarma

Analyst coverage of Kimberly Clark on Smartkarma has been insightful, with reports from Baptista Research shedding light on the company’s recent performance and strategic moves. In one report titled “Kimberly-Clark Corporation: Optimized pricing and volume mix strategy could be a game changer? – Major Drivers“, the analysts highlighted the steady growth and challenges in Kimberly-Clark’s recent earnings for the fourth quarter and full year 2023. The company’s focus on elevating categories and expanding markets for growth showed promising results, despite supply constraints impacting its market share.

Another report by Baptista Research, titled “Kimberly-Clark Corporation: Is It The Market’s Hidden Gem? – Major Drivers“, discussed the mixed results of the previous quarter, with revenues falling below analyst consensus. The strategic exit from the Brazil tissue business had a notable impact, reducing net sales and affecting Consumer Tissue and the Professional business segments. Despite these challenges, Consumer Tissue still managed to report 2% organic growth, with North America driving a strong 4% organic growth due to high demand for dry baths and towels.


A look at Kimberly Clark Smart Scores

FactorScoreMagnitude
Value2
Dividend4
Growth3
Resilience2
Momentum4
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Kimberly-Clark Corporation, a global health and hygiene company known for its consumer products like diapers, tissues, and paper towels, has received favorable Smartkarma Smart Scores. With a high score in Dividend and Momentum, the company is positioned well for long-term growth and stability. The strong Dividend score indicates that Kimberly-Clark is committed to rewarding its investors, while the robust Momentum score suggests positive market sentiment and potential for continued upward movement in the stock price.

While the Value and Resilience scores are moderate, the Growth score sits at a promising level. This indicates that Kimberly-Clark has room for expansion and innovation in its product offerings. Overall, with its strong emphasis on dividends and positive market momentum, Kimberly-Clark presents a compelling outlook for investors looking at the company’s long-term prospects as a solid investment choice.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars